ACKNOWLEDGMENTS
We thank the study participants and their families. The CHICO SECURE Study Group members are listed in the supplemental material. We sincerely thank LAT Research, Buenos Aires, Argentina, for excellent support in conducting the study. We also wish to thank the laboratory of Stamboulian Health Services, Buenos Aires, Argentina, for technical assistance in the analyses of patient samples. We acknowledge Highfield Communication, Oxford, United Kingdom, funded by Bayer AG, for medical writing and editorial support.J.A. acted as a consultant to Bayer for the design, conduct and review of the CHICO and CHICO SECURE studies. U.G. is an employee of Bayer AG (Berlin, Germany). E.H. is an employee of Bayer US LLC (Whippany, New Jersey, USA). G.M. received personal fees from Bayer during the conduct of the study. O.D. is an employee of Bayer Healthcare Co., Ltd. (Shanghai, China).V.S., T.R., and J.J.P.R. have no conflicts of interest to disclose.Supplemental material is available online only.
Supplemental material. Download 